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Background
The newer fourth generation HIV ELISA has been
shown to have an increased sensitivity compared to
third generation ELISA.
Objectives
To estimate the yield of fourth generation HIV ELISA
compared to third generation HIV ELISA assay and to
determine HIV seroprevalence among blood donors.
Materials and methods
This prospective study involved 10200 blood donors –
6800 voluntary donors (3400 – students and 3400 –
non students) and 3400 replacement donors. All blood
units were tested using third and fourth generation
ELISA. All positive & borderline positive samples were
confirmed by Western Blot (WB).
Results
The HIV seroprevalence was estimated to be 1.37/1000
donations with 3rd generation and 3.62/1000 donations
with 4th generation ELISA (p>0.05). Of the 17 samples
which were 4th generation ELISA positive and WB posi-
tive, 11 were positive with 3rd generation ELISA. Fourth
generation ELISA tested 19 additional samples positive
and 7 samples as possibly positive which were tested
negative with 3rd generation ELISA, giving an additional
yield of 26 window period units per 10200 donations i.e.
2.5/1000 donations. Of these, 6 were WB positive giving
a yield of 0.58 window period units per 1000 donations.
Since 2-3 components are prepared from each blood
unit, the yield can be increased to 12-18/10200
donations. With an annual donation of nearly 46000
blood units, this will be 54-81 positive samples per
10200 donations.
Conclusions
Prevention of 54-81 individuals from acquiring new
transfusion transmitted HIV infection with the newer
fourth generation HIV ELISA assay with better perfor-
mance and comparable cost is a cost-effective strategy.
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